{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:42:01Z","timestamp":1761561721854,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.carrev.2010.11.006","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T04:37:14Z","timestamp":1296103034000},"page":"262-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV\/HCV coinfection: case report and review of the literature"],"prefix":"10.1016","volume":"12","author":[{"given":"Giancarlo","family":"Ceccarelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"d'Ettorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Mancone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Francone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2010.11.006_bb0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/187152908786786232","article-title":"Cardiovascular effects of antiretroviral drugs: clinical review","volume":"8","author":"Filardi","year":"2008","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.carrev.2010.11.006_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11883-010-0089-4","article-title":"The spectrum of atherosclerotic coronary artery disease in HIV patients","volume":"12","author":"Hakeem","year":"2010","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.carrev.2010.11.006_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/CRD.0b013e3181b151a3","article-title":"Human immunodeficiency virus and atherosclerosis","volume":"17","author":"Farrugia","year":"2009","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.carrev.2010.11.006_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/QCO.0b013e328320a849","article-title":"Cardiovascular disease and HIV infection: host, virus, or drugs?","volume":"22","author":"Mart\u00ednez","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.carrev.2010.11.006_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1742-1241.2009.02248.x","article-title":"Coronary heart disease risk assessment in HIV-infected patients: a comparison of Framingham, PROCAM and SCORE risk assessment functions","volume":"64","author":"Moreira Guimar\u00e3es","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.carrev.2010.11.006_bb0030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","article-title":"Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study","volume":"17","author":"Friis-M\u00f8ller","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.carrev.2010.11.006_bb0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/apc.2009.0048","article-title":"Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection","volume":"23","author":"Lai","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.carrev.2010.11.006_bb0040","article-title":"Percutaneous coronary intervention in patients infected with human immunodeficiency virus admitted with an acute coronary syndrome: Case-control study","author":"Mart\u00edn-Reyes","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.carrev.2010.11.006_bb0045","first-page":"879","article-title":"Outcome of percutaneous coronary intervention in HIV-infected patients","volume":"68","author":"Segev","year":"2006","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2010.11.006_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.163.4.457","article-title":"Acute myocardial infarction in human immunodeficiency virus-infected patients","volume":"163","author":"Matetzky","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.carrev.2010.11.006_bb0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/hrt.2005.068445","article-title":"Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis","volume":"92","author":"Boccara","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2010.11.006_bb0060","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2174\/092986708786848668","article-title":"Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures","volume":"15","author":"De Lorenzo","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.carrev.2010.11.006_bb0065","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/COH.0b013e3281e38a98","article-title":"Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!","volume":"2","author":"van Leuven","year":"2007","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.carrev.2010.11.006_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1253\/circj.CJ-09-0706","article-title":"Inflammation in atherosclerosis: transition from theory to practice","volume":"74","author":"Libby","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2010.11.006_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clim.2009.12.005","article-title":"Innate immunity and chronic immune activation in HCV\/HIV-1 co-infection","volume":"135","author":"Gonzalez","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.carrev.2010.11.006_bb0080","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","article-title":"Immune activation in patients with irritable bowel syndrome","volume":"132","author":"Liebregts","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.carrev.2010.11.006_bb0085","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1538-7836.2009.03586.x","article-title":"Platelet functions beyond hemostasis","volume":"7","author":"Smyth","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.carrev.2010.11.006_bb0090","doi-asserted-by":"crossref","first-page":"12082","DOI":"10.1128\/JVI.01466-10","article-title":"Reduction of Immune Activation during Chronic HIV Infection with chloroquine therapy","volume":"84","author":"Murray","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.carrev.2010.11.006_bb0095","doi-asserted-by":"crossref","first-page":"11407","DOI":"10.1128\/JVI.01211-09","article-title":"High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus Type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment","volume":"83","author":"Gonzalez","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.carrev.2010.11.006_bb0100","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.healun.2004.07.018","article-title":"Inflammatory response and re-stenosis after percutaneous coronary intervention in heart transplant recipients and patients with native atherosclerosis","volume":"24","author":"Hognestad","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.carrev.2010.11.006_bb0105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2009.04.015","article-title":"Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study","volume":"207","author":"Momiyama","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.carrev.2010.11.006_bb0110","first-page":"11","article-title":"The Hiv-1\/Haart Associated Metabolic Syndrome\u2014novel adipokines, molecular associations and therapeutic implications","author":"Tsiodras","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.carrev.2010.11.006_bb0115","doi-asserted-by":"crossref","first-page":"568343","DOI":"10.1155\/2010\/568343","article-title":"Role of leptin in the activation of immune cells","volume":"2010","author":"Fern\u00e1ndez-Riejos","year":"2010","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.carrev.2010.11.006_bb0120","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/CIRCRESAHA.107.164988","article-title":"Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis","volume":"102","author":"Okamoto","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2010.11.006_bb0125","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat Med"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838910002277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838910002277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:07:49Z","timestamp":1761559669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838910002277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1553838910002277"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2010.11.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV\/HCV coinfection: case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2010.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}